Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
AngioDynamics typically reports before the market opens, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-14 | +$0.22 (+1.76%) | $1.33 (10.41%) | +$1.47 (+11.31%) | $1.96 (15.04%) |
| 2026-04-02 | -$1.63 (-13.65%) | $1.64 (13.73%) | -$0.47 (-4.56%) | $0.77 (7.47%) |
| 2025-10-02 | +$0.67 (+6.05%) | $1.41 (12.70%) | -$0.10 (-0.85%) | $0.56 (4.77%) |
| 2025-07-15 | -$0.98 (-10.18%) | $2.18 (22.59%) | -$0.05 (-0.58%) | $0.62 (7.11%) |
| 2025-04-02 | +$1.20 (+12.42%) | $1.51 (15.63%) | -$1.04 (-9.58%) | $0.72 (6.68%) |
| 2025-01-08 | +$3.54 (+37.66%) | $1.63 (17.33%) | -$0.64 (-4.95%) | $0.82 (6.34%) |
| 2024-10-03 | -$1.28 (-16.73%) | $0.86 (11.18%) | -$0.27 (-4.24%) | $0.55 (8.63%) |
| 2024-07-16 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 14.07% | 14.80% | 5.15% | 8.00% |
Historical price behavior shows significant volatility on earnings day, with Day 0 moves averaging 14.07% in absolute terms and ranging as wide as 14.80% on average. The most recent report on July 14, 2026, saw a relatively modest +1.76% Day 0 move, well below the historical average, followed by substantial +11.31% follow-through on Day +1.
The pattern reveals that ANGO's initial reactions can be dramatic — the January 2025 report produced a +37.66% Day 0 surge, while October 2024 saw a -16.73% decline. However, Day +1 moves are typically more moderate, averaging 5.15% in absolute terms with an 8.00% average range. This suggests the market often takes time to fully digest results, with initial volatility sometimes giving way to more measured reassessment in the following session. Investors should prepare for substantial price swings, particularly on the day of the announcement.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 10/16/26 (DTE 9) |
| Expected Move | $1.80 (12.70%) |
| Expected Range | $12.39 to $15.99 |
| Implied Volatility | 133.62% |
The options market is pricing an expected move of ±12.70% for the October 16 expiration, which sits below the stock's historical Day 0 average move of 14.07% but above the Day +1 average of 5.15%. This suggests options traders are anticipating somewhat less volatility than ANGO has typically delivered on earnings day, though still expecting meaningful movement.
Part 3: What Analysts Are Saying
Analyst sentiment on AngioDynamics has improved significantly, with the consensus now firmly bullish. The average recommendation stands at 4.60 out of 5, reflecting strong conviction among the analyst community. The current breakdown shows 4 Strong Buy ratings and 1 Hold, with no sell recommendations.
The shift in sentiment is notable: one month ago, the average recommendation was 4.20 with one Strong Sell rating still on the books. That analyst has since either upgraded or dropped coverage, contributing to the improved outlook. The average price target of $18.60 implies 31% upside from the current price of $14.19, with the range spanning from a low of $13.00 to a high of $24.00. The high-end target suggests some analysts see potential for nearly 70% appreciation if the company executes on its growth strategy.
The concentration of Strong Buy ratings indicates analysts believe ANGO's turnaround story is gaining traction, with the Med Tech segment's growth potential and improving profitability metrics driving optimism. However, the wide spread in price targets — from $13.00 to $24.00 — reflects uncertainty about execution timing and the pace at which the company can achieve sustained profitability.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a Buy signal at 40%, representing a significant weakening from last week's 80% Buy and last month's 80% Buy. This deterioration in technical momentum heading into earnings suggests near-term consolidation or profit-taking has dampened the bullish setup.
Timeframe Analysis:
- Short-term (Hold): Neutral signal indicates near-term momentum has stalled after recent weakness
- Medium-term (50% Buy): Moderate buy signal suggests the intermediate trend remains constructive despite recent pullback
- Long-term (100% Buy): Strong buy signal reflects solid longer-term uptrend remains intact
Trend Characteristics: The trend is characterized as Average strength in the Weakest direction, indicating that while the underlying trend structure remains intact, momentum has clearly faded heading into the earnings event.
The stock is currently trading below its 5-day ($14.88), 10-day ($15.17), 20-day ($15.31), and 50-day ($15.45) moving averages, confirming recent weakness in the near-term trend. However, ANGO remains above its 100-day ($14.00) and 200-day ($12.50) moving averages, indicating the longer-term uptrend established earlier this year is still intact.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $14.88 | 50-Day MA | $15.45 |
| 10-Day MA | $15.17 | 100-Day MA | $14.00 |
| 20-Day MA | $15.31 | 200-Day MA | $12.50 |
The technical setup heading into earnings is mixed to cautious. While the longer-term trend remains supportive with the stock well above its 200-day moving average, the recent breakdown below all shorter-term moving averages and the sharp deterioration in the Barchart Technical Opinion signal suggest momentum has stalled. The stock's position at $14.19 sits just above the 100-day moving average at $14.00, which now represents critical support. A strong earnings beat could provide the catalyst needed to reclaim the 50-day moving average and reignite bullish momentum, but a disappointment could test the 100-day support level. Given the expected move of ±12.70% and the stock's history of volatile post-earnings reactions, traders should be prepared for a decisive break in either direction.